XML 29 R17.htm IDEA: XBRL DOCUMENT v3.7.0.1
Financial Instruments
6 Months Ended
Jun. 30, 2017
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Financial Instruments
FINANCIAL INSTRUMENTS

Derivative Instruments
The Company is exposed to a variety of market risks, including the effects of changes in foreign currency exchange rates and interest rates. The Company’s risk management strategy includes the use of derivative instruments to reduce the effects on its operating results and cash flows from fluctuations caused by volatility in currency exchange rates.

The Company serves many of its U.S.-based clients using contact center capacity outside of the U.S. Although the contracts with these clients are typically priced in U.S. dollars, a substantial portion of the costs incurred to deliver services under these contracts are denominated in the local currency of the country where services are provided, which represents a foreign exchange exposure. The Company has hedged a portion of its exposure related to the anticipated cash flow requirements denominated in some of the aforementioned foreign currencies by entering into hedging contracts with several financial institutions to acquire a total of PHP 36,765.0 at a fixed price of $745.4 at various dates through March 2020, INR 12,435.0 at a fixed price of $171.0 at various dates through March 2020, CAD 54.8 at a fixed price of $41.5 at various dates through December 2019 and COP 28,200.0 at a fixed price of $8.9 at various dates through December 2018, and to sell a total of AUD 18.0 at a fixed price of $13.4 at various dates through March 2018. These instruments mature within the next 33 months and had a notional value of $964.9 at June 30, 2017 and $959.0 at December 31, 2016. The derivative instruments discussed above are designated and are effective as cash flow hedges. The following table reflects the fair values of these derivative instruments:
 
  
June 30, 2017
December 31, 2016
Forward exchange contracts and options designated as hedging instruments:
 
 
Included within other current assets

$9.2


$3.0

Included within other non-current assets
6.0

2.3

Included within other current liabilities
21.7

31.3

Included within other long-term liabilities
9.4

15.4


 
The Company recorded a deferred tax benefit of $6.1 and $15.9 related to these derivatives at June 30, 2017 and December 31, 2016, respectively. A total of $9.8 and $25.5 of deferred losses, net of tax, related to these cash flow hedges at June 30, 2017 and December 31, 2016, respectively, were included in accumulated other comprehensive loss (OCL). As of June 30, 2017, deferred losses of $12.5 ($7.7 net of tax) on derivative instruments included in accumulated OCL are expected to be reclassified into earnings during the next 12 months. The following tables provide the effect of these derivative instruments on the Company’s Consolidated Financial Statements during the three and six months ended June 30, 2017 and 2016, respectively:

Derivatives in Cash Flow Hedging Relationships
Gain (Loss)
Recognized
in OCL on
Derivative
(Effective Portion)
Gain (Loss)
Reclassified
from Accumulated
OCL into Income
(Effective Portion)
Location of
Gain (Loss)
Reclassified from
Accumulated OCL
into Income
(Effective Portion)
Three Months Ended June 30, 2017
 
 
 
Foreign exchange contracts

$3.0


($5.1
)
Cost of providing services and products sold and Selling, general and administrative
Six Months Ended June 30, 2017
 
 
 
Foreign exchange contracts

$12.8


($12.8
)
Cost of providing services and products sold and Selling, general and administrative
Three Months Ended June 30, 2016
 
 
 
Foreign exchange contracts

($16.0
)

($4.6
)
Cost of providing services and products sold and Selling, general and administrative
Six Months Ended June 30, 2016
 
 
 
Foreign exchange contracts

$11.1


($13.3
)
Cost of providing services and products sold and Selling, general and administrative



The gain or loss recognized related to the ineffective portion of the derivative instruments was immaterial for the three months ended June 30, 2017 and 2016.
 
The Company also enters into derivative instruments (forwards) to economically hedge the foreign currency impact of assets and liabilities denominated in nonfunctional currencies. During the six months ended June 30, 2017, a loss of $12.0 was recognized related to changes in fair value of these derivative instruments not designated as hedges, compared to a gain of $1.0 in the same period in 2016. The gains and losses largely offset the currency gains and losses that resulted from changes in the assets and liabilities denominated in nonfunctional currencies. These gains and losses are classified within other income, net in the accompanying Consolidated Statements of Income. The fair value of these derivative instruments not designated as hedges at June 30, 2017 was a $3.0 payable.
 

Short-term Investments
As of June 30, 2017 and December 31, 2016, the Company held investment securities with a fair value of $12.2 and $12.4, respectively, that are held in a grantor trust for the benefit of participants in the EDCP and reflect the hypothetical investment balances of EDCP participants. The securities are classified as trading securities and included within short-term investments in the Consolidated Balance Sheets. The investment securities include exchange-traded mutual funds and money market accounts. These securities are carried at fair value, with gains and losses, both realized and unrealized, reported in other income (expense), net in the Consolidated Statements of Income. The cost of securities sold is based upon the specific identification method. Interest and dividends on securities classified as trading are included in other income (expense), net.